A review of the formation and classification of amphiphilic block copolymer nanoparticulate structures: micelles, nanospheres, nanocapsules and polymersomes.
暂无分享,去创建一个
[1] Stanislaus S. Wong,et al. Block Copolymer "Crew-Cut" Micelles in Water , 1994 .
[2] I. Kwon,et al. Amphiphilic Diblock Copolymers Based on Poly(2-ethyl-2-oxazoline) and Poly(1,3-trimethylene carbonate): Synthesis and Micellar Characteristics , 2000 .
[3] A. Lavasanifar,et al. Micelles of methoxy poly(ethylene oxide)-b-poly(epsilon-caprolactone) as vehicles for the solubilization and controlled delivery of cyclosporine A. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[4] J. Kreuter,et al. Influence of the surface properties of low contact angle surfactants on the body distribution of 14C-poly(methyl methacrylate) nanoparticles. , 1992, Journal of microencapsulation.
[5] Alexander V. Kabanov,et al. Effects of Pluronic Block Copolymers on Drug Absorption in Caco-2 Cell Monolayers , 1998, Pharmaceutical Research.
[6] Chi-Hwa Wang,et al. Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel , 2005, Pharmaceutical Research.
[7] J. Leroux,et al. Synthesis and Micellar Characterization of Novel Amphiphilic A−B−A Triblock Copolymers of N-(2-Hydroxypropyl)methacrylamide or N-Vinyl-2-pyrrolidone with Poly(ε-caprolactone) , 2002 .
[8] Lifeng Zhang,et al. Thermodynamic vs kinetic aspects in the formation and morphological transitions of crew-cut aggregates produced by self-assembly of polystyrene-b-poly(acrylic acid) block copolymers in dilute solution , 1999 .
[9] R. Jerome,et al. About the methods of preparation of poly(ethylene oxide)-b-poly(ε-caprolactone) nanoparticles in water Analysis by dynamic light scattering , 2004 .
[10] A. Kabanov,et al. Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer. , 1996, Bioconjugate chemistry.
[11] Chong-Su Cho,et al. METHOXY POLY(ETHYLENE GLYCOL) AND CAPROLACTONE AMPHIPHILIC BLOCK CO POLYMERIC MICELLE CONTAINING INDOMETHACIN. II: MICELLE FORMATION AND DRUG RELEASE BEHAVIORS , 1998 .
[12] Y. M. Lee,et al. Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsilon-caprolactone) as novel anticancer drug carriers. , 2001, Biomaterials.
[13] G. Kwon,et al. Diblock copolymer nanoparticles for drug delivery. , 1998, Critical reviews in therapeutic drug carrier systems.
[14] D. Maysinger,et al. Polycaprolactone-b-poly(ethylene oxide) copolymer micelles as a delivery vehicle for dihydrotestosterone. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[15] V. Torchilin,et al. Biodegradable long-circulating polymeric nanospheres. , 1994, Science.
[16] Liandong Deng,et al. Methoxy Poly(ethylene glycol)-b-Poly(L-lactic acid) Copolymer Nanoparticles as Delivery Vehicles for Paclitaxel , 2005 .
[17] T. A. Hatton,et al. Micellization of poly(ethylene oxide)-poly(propylene oxide)-poly(ethylene oxide) triblock copolymers in aqueous solutions: Thermodynamics of copolymer association , 1994 .
[18] Dennis E Discher,et al. Self-porating polymersomes of PEG-PLA and PEG-PCL: hydrolysis-triggered controlled release vesicles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[19] S. Davis,et al. An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. , 1993, Biochimica et biophysica acta.
[20] P. Gellert,et al. Poly(lactic acid)−Poly(ethylene oxide) (PLA−PEG) Nanoparticles: NMR Studies of the Central Solidlike PLA Core and the Liquid PEG Corona , 2002 .
[21] Daniel A. Hammer,et al. Molecular Weight Dependence of Polymersome Membrane Structure, Elasticity, and Stability , 2002 .
[22] P. Legrand,et al. Polyester-Poly(Ethylene Glycol) Nanoparticles Loaded with the Pure Antiestrogen RU 58668: Physicochemical and Opsonization Properties , 2003, Pharmaceutical Research.
[23] T. Okano,et al. Process design for efficient and controlled drug incorporation into polymeric micelle carrier systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[24] T. A. Hatton,et al. Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling , 1995 .
[25] R. Liggins,et al. Synthesis and micellar characterization of short block length methoxy poly(ethylene glycol)-block-poly(caprolactone) diblock copolymers. , 2004, Colloids and surfaces. B, Biointerfaces.
[26] Pavel Kratochvíl,et al. Micelles of Block and Graft Copolymers in Solutions , 1993 .
[27] Yong Zhang,et al. In‐vitro cytotoxicity, in‐vivo biodistribution and anti‐tumour effect of PEGylated liposomal topotecan , 2005, The Journal of pharmacy and pharmacology.
[28] A. Schaper,et al. Core-cross-linked polymeric micelles as paclitaxel carriers. , 2004, Bioconjugate chemistry.
[29] S. W. Kim,et al. Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. , 1998, Journal of biomedical materials research.
[30] E. K. Park,et al. Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumor-targeted drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[31] Alexander V Kabanov,et al. Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers. , 2002, Critical reviews in therapeutic drug carrier systems.
[32] K. Kataoka,et al. Block copolymer micelles for drug delivery: design, characterization and biological significance. , 2001, Advanced drug delivery reviews.
[33] A. R. Kulkarni,et al. Biodegradable polymeric nanoparticles as drug delivery devices. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[34] Martin C. Garnett,et al. Physicochemical Evaluation of Nanoparticles Assembled from Poly(lactic acid)−Poly(ethylene glycol) (PLA−PEG) Block Copolymers as Drug Delivery Vehicles , 2001 .
[35] Robert Langer,et al. PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1 , 1997 .
[36] Hatem Fessi,et al. Nanocapsule formation by interfacial polymer deposition following solvent displacement , 1989 .
[37] A. Eisenberg,et al. 1998 E.W.R. Steacie Award Lecture Asymmetric amphiphilic block copolymers in solution: a morphological wonderland , 1999 .
[38] John Samuel,et al. Poly(ethylene oxide)-block-poly(L-amino acid) micelles for drug delivery. , 2002, Advanced drug delivery reviews.
[39] Teruo Okano,et al. Preparation and Characterization of the Micelle-Forming Polymeric Drug Indomethacin-lncorporated Polyfethylene oxide)-Poly(β-benzyl L-aspartate) Block Copolymer Micelles , 1996 .
[40] T. Allen. The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system , 1994 .
[41] Y. M. Lee,et al. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[42] R. Dorr. Pharmacology and Toxicology of Cremophor EL Diluent , 1994, The Annals of pharmacotherapy.
[43] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[44] Kazuo Maruyama,et al. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.
[45] S. Davis,et al. The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338) , 1984, FEBS letters.
[46] H. Fessi,et al. Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-Out, Emulsification-Diffusion, and Nanoprecipitation Methods , 2004, Pharmaceutical Research.
[47] Y. M. Lee,et al. Amphiphilic diblock copolymeric nanospheres composed of methoxy poly(ethylene glycol) and glycolide: properties, cytotoxicity and drug release behaviour. , 1999, Biomaterials.
[48] T. Okano,et al. Biodistribution of Micelle-Forming Polymer–Drug Conjugates , 1993, Pharmaceutical Research.
[49] J. Leroux,et al. Novel pH-sensitive supramolecular assemblies for oral delivery of poorly water soluble drugs: preparation and characterization. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[50] H. Burt,et al. Evidence for Modulation of P-glycoprotein-Mediated Efflux by Methoxypolyethylene Glycol-block-Polycaprolactone Amphiphilic Diblock Copolymers , 2004, Pharmaceutical Research.
[51] A. Halperin. Polymeric micelles: a star model , 1987 .
[52] Hua Ai,et al. Micellar carriers based on block copolymers of poly(ε-caprolactone) and poly(ethylene glycol) for doxorubicin delivery , 2004 .
[53] Lifeng Zhang,et al. Phase Separation Behavior and Crew-Cut Micelle Formation of Polystyrene-b-poly(acrylic acid) Copolymers in Solutions , 1997 .
[54] S. Davis,et al. The effect of hydrophilic coatings on the uptake of colloidal particles by the liver and by peritoneal macrophages , 1986 .
[55] Kazunori Kataoka,et al. Block copolymer micelles as long-circulating drug vehicles , 1995 .
[56] R. Liggins,et al. Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations. , 2002, Advanced drug delivery reviews.
[57] Hideyoshi Harashima,et al. Enhanced Hepatic Uptake of Liposomes Through Complement Activation Depending on the Size of Liposomes , 1994, Pharmaceutical Research.
[58] F. Bates,et al. Polymer vesicles in vivo: correlations with PEG molecular weight. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[59] Egon Matijević,et al. Surface and Colloid Science , 1971 .
[60] Christine Allen,et al. Nano-engineering block copolymer aggregates for drug delivery , 1999 .
[61] Dennis E. Discher,et al. Polymer vesicles : Materials science: Soft surfaces , 2002 .
[62] S. Davis,et al. Nanoparticles in drug delivery. , 1987, Critical reviews in therapeutic drug carrier systems.
[63] D. Hammer,et al. Polymersomes: tough vesicles made from diblock copolymers. , 1999, Science.
[64] Y. M. Lee,et al. Indomethacin-loaded methoxy poly(ethylene glycol)/poly(ε-caprolactone) diblock copolymeric nanosphere: pharmacokinetic characteristics of indomethacin in the normal Sprague–Dawley rats , 2001 .
[65] Yechezkel Barenholz,et al. Pharmacokinetics of Pegylated Liposomal Doxorubicin , 2003, Clinical pharmacokinetics.
[66] A. Eisenberg,et al. Morphogenic Effect of Solvent on Crew-Cut Aggregates of Apmphiphilic Diblock Copolymers , 1998 .
[67] Giulio F. Paciotti,et al. Colloidal gold nanoparticles: a novel nanoparticle platform for developing multifunctional tumor‐targeted drug delivery vectors , 2006 .
[68] R. Liggins,et al. Enhanced cellular accumulation of a P-glycoprotein substrate, rhodamine-123, by Caco-2 cells using low molecular weight methoxypolyethylene glycol-block-polycaprolactone diblock copolymers. , 2002, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[69] M. Jones,et al. Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[70] Martyn C. Davies,et al. Polystyrene-Poly (Ethylene Glycol) (PS-PEG2000) Particles as Model Systems for Site Specific Drug Delivery. 2. The Effect of PEG Surface Density on the in Vitro Cell Interaction and in VivoBiodistribution , 1994, Pharmaceutical Research.
[71] W. Hunter,et al. Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel , 1999 .
[72] M. Alonso,et al. Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[73] R. Müller,et al. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. , 1995, Advanced drug delivery reviews.
[74] Catarina Pinto Reis,et al. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles. , 2006, Nanomedicine : nanotechnology, biology, and medicine.
[75] R. Müller,et al. Surface modification of i.v. injectable biodegradable nanoparticles with poloxamer polymers and poloxamine 908 , 1993 .
[76] Y. Jeong,et al. Preparation of core–shell type nanoparticles of diblock copolymers of poly(L-lactide)/poly(ethylene glycol) and their characterization in vitro , 2002 .
[77] T. Okano,et al. Doxorubicin-loaded poly(ethylene glycol)-poly(beta-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[78] M. Prato,et al. Functionalized carbon nanotubes as emerging nanovectors for the delivery of therapeutics. , 2006, Biochimica et biophysica acta.
[79] Teruo Okano,et al. Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-Adriamycin conjugates , 1994 .
[80] M. Alonso,et al. Chitosan-PEG nanocapsules as new carriers for oral peptide delivery. Effect of chitosan pegylation degree. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[81] D. Devine,et al. Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.
[82] E. L. Senna,et al. Preparation and Characterization of Poly(D,L-Lactide) (PLA) and Poly(D,L-Lactide)-Poly(Ethylene Glycol) (PLA-PEG) Nanocapsules Containing Antitumoral Agent Methotrexate , 2005 .
[83] Lifeng Zhang,et al. Multiple Morphologies of "Crew-Cut" Aggregates of Polystyrene-b-poly(acrylic acid) Block Copolymers , 1995, Science.
[84] J. Kreuter,et al. Contact angles of surfactants with a potential to alter the body distribution of colloidal drug carriers on poly(methyl methacrylate) surfaces , 1988 .
[85] T. Park,et al. Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[86] Alfred N. Martin. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences , 1969 .
[87] Christine Allen,et al. Polymer-drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine. , 2004, Journal of pharmaceutical sciences.
[88] John K. Jackson,et al. Development of amphiphilic diblock copolymers as micellar carriers of taxol , 1996 .
[89] A. Eisenberg,et al. Multiple Morphologies and Characteristics of “Crew-Cut” Micelle-like Aggregates of Polystyrene-b-poly(acrylic acid) Diblock Copolymers in Aqueous Solutions , 1996 .
[90] Markus Antonietti,et al. Micellization of strongly segregated block copolymers , 1996 .
[91] Kui Yu,et al. Ion-Induced Morphological Changes in “Crew-Cut” Aggregates of Amphiphilic Block Copolymers , 1996, Science.
[92] Jean-Pierre Benoit,et al. Parameters influencing the stealthiness of colloidal drug delivery systems. , 2006, Biomaterials.
[93] T. Okano,et al. Micelles based on AB block copolymers of poly(ethylene oxide) and poly(.beta.-benzyl L-aspartate) , 1993 .
[94] Alexander V Kabanov,et al. Pluronic block copolymers for overcoming drug resistance in cancer. , 2002, Advanced drug delivery reviews.